212 related articles for article (PubMed ID: 9668089)
1. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Jul; 273(30):19065-71. PubMed ID: 9668089
[TBL] [Abstract][Full Text] [Related]
2. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
Zhao R; Gao F; Goldman ID
Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
[TBL] [Abstract][Full Text] [Related]
3. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
Zhao R; Assaraf YG; Goldman ID
J Biol Chem; 1998 Apr; 273(14):7873-9. PubMed ID: 9525881
[TBL] [Abstract][Full Text] [Related]
4. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.
Zhao R; Seither R; Brigle KE; Sharina IG; Wang PJ; Goldman ID
J Biol Chem; 1997 Aug; 272(34):21207-12. PubMed ID: 9261128
[TBL] [Abstract][Full Text] [Related]
5. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
Sierra EE; Goldman ID
Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
[TBL] [Abstract][Full Text] [Related]
6. Role of the amino acid 45 residue in reduced folate carrier function and ion-dependent transport as characterized by site-directed mutagenesis.
Zhao R; Gao F; Wang PJ; Goldman ID
Mol Pharmacol; 2000 Feb; 57(2):317-23. PubMed ID: 10648641
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Spinella MJ; Brigle KE; Sierra EE; Goldman ID
J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
Sierra EE; Brigle KE; Spinella MJ; Goldman ID
Biochem Pharmacol; 1995 Oct; 50(8):1287-94. PubMed ID: 7488246
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier.
Sharina IG; Zhao R; Wang Y; Babani S; Goldman ID
Mol Pharmacol; 2001 May; 59(5):1022-8. PubMed ID: 11306683
[TBL] [Abstract][Full Text] [Related]
10. Residues 45 and 404 in the murine reduced folate carrier may interact to alter carrier binding and mobility.
Zhao R; Wang Y; Gao F; Goldman ID
Biochim Biophys Acta; 2003 Jun; 1613(1-2):49-56. PubMed ID: 12832086
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
Zhao R; Gao F; Babani S; Goldman ID
Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
[TBL] [Abstract][Full Text] [Related]
12. Membrane protein changes in an L1210 leukemia cell line with a translocation defect in the methotrexate-tetrahydrofolate cofactor transport carrier.
Schuetz JD; Westin EH; Matherly LH; Pincus R; Swerdlow PS; Goldman ID
J Biol Chem; 1989 Sep; 264(27):16261-7. PubMed ID: 2777791
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line.
Brigle KE; Spinella MJ; Sierra EE; Goldman ID
J Biol Chem; 1995 Sep; 270(39):22974-9. PubMed ID: 7559435
[TBL] [Abstract][Full Text] [Related]
14. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
[TBL] [Abstract][Full Text] [Related]
15. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
[TBL] [Abstract][Full Text] [Related]
16. Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cell lines with a defective reduced folate carrier.
Brigle KE; Seither RL; Westin EH; Goldman ID
J Biol Chem; 1994 Feb; 269(6):4267-72. PubMed ID: 8307991
[TBL] [Abstract][Full Text] [Related]
17. Carrier-mediated transport of folate compounds in L1210 cells. Initial rate kinetics and extent of duality of entry routes for folic acid and diastereomers of 5-methyltetrahydrohomofolate in the presence of physiological anions.
Sirotnak FM; Goutas LJ; Jacobsen DM; Mines LS; Barrueco JR; Gaumont Y; Kisliuk RL
Biochem Pharmacol; 1987 May; 36(10):1659-67. PubMed ID: 3593392
[TBL] [Abstract][Full Text] [Related]
18. Role of the E45K-reduced folate carrier gene mutation in methotrexate resistance in human leukemia cells.
Gifford AJ; Haber M; Witt TL; Whetstine JR; Taub JW; Matherly LH; Norris MD
Leukemia; 2002 Dec; 16(12):2379-87. PubMed ID: 12454742
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells.
Roy K; Tolner B; Chiao JH; Sirotnak FM
J Biol Chem; 1998 Jan; 273(5):2526-31. PubMed ID: 9446553
[TBL] [Abstract][Full Text] [Related]
20. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
